IP Library Granted Patent US 7,569,682
Granted Patent B2
US 7,569,682 · App. 11/833,632 · Granted Aug 4, 2009

Patent

Assignee: Intervet International B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,682
App. No.
11/833,632
Granted
Aug 4, 2009
Kind
B2
Abstract

The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 30 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, lipoproteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, lipoprotein or antibodies against such lipoprotein.

Claims (5)

1. An expression vector comprising a nucleic acid that encodes the protein sequence set forth in SEQ ID NO: 5.

2. The expression vector of claim 1 , wherein said nucleic acid is under the control of a functionally linked promoter.

3. A live recombinant carrier comprising the expression vector of claim 1 .

4. A host cell comprising the expression vector of claim 1 .

5. A host cell comprising the live recombinant carrier of claim 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2007
From: AKZO NOBEL N.V.
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 020235/0085 →
Priority Claims (1)
EP 02076800 · May 8, 2002 · regional
Continuity (2)
Continuation 1051405400
Related Publication 20080063655A1 · Mar 13, 2008